German Dementia Registry
Key facts
- Where
- Aachen, Berlin, Bremen, Cologne, Erlangen, Essen, Frankfurt (Oder), Göttingen, Greifswald, Hamburg, Heidelberg, Homburg, Jena, Kiel, Klingenmünster, Leipzig, Magdeburg, Mainz, Mannheim, Rüdersdorf, Tübingen és Ulm, NémetországSee the 24 sites
Where in Németország
- RWTH Aachen University HospitalAachen, NémetországTaking people
- Charité Campus Benjamin FranklinBerlin, NémetországTaking people
- Charité Universitätsmedizin BerlinBerlin, NémetországTaking people
- Klinikum Bremen-OstBremen, NémetországTaking people
- University Hospital CologneCologne, NémetországToborzás még nem indult
- Universitätsklinikum ErlangenErlangen, NémetországTaking people
- University Hospital EssenEssen, NémetországTaking people
- Klinikum Frankfurt (Oder)Frankfurt (Oder), NémetországTaking people
- University Medical Center GöttingenGöttingen, NémetországTaking people
- Greifswald University MedicineGreifswald, NémetországTaking people
- Asklepios Klinik NordHamburg, NémetországTaking people
- Medical Center Hamburg-EppendorfHamburg, NémetországTaking people
- Heidelberg University HospitalHeidelberg, NémetországTaking people
- Saarland University Medical CenterHomburg, NémetországTaking people
- University Hospital JenaJena, NémetországToborzás még nem indult
- University Hospital Schleswig-HolsteinKiel, NémetországTaking people
- Pfalzklinikum KlingenmünsterKlingenmünster, NémetországTaking people
- University of Leipzig Medical CenterLeipzig, NémetországTaking people
- Madical Faculty University Hospital MagdeburgMagdeburg, NémetországTaking people
- University Medical Center MainzMainz, NémetországToborzás még nem indult
- ZI MannheimMannheim, NémetországTaking people
- Immanuel Klinik RüdersdorfRüdersdorf, NémetországTaking people
- University Hospital TübingenTübingen, NémetországTaking people
- Ulm University HospitalUlm, NémetországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- RWTH Aachen University
- Trial code
- NCT07433010
- Record updated
- 2026. február 25.
- Original description
The German Dementia Registry (DEMREG) is a large-scale national prospective biomarker-based study for cognitive impairment and dementia, providing an integrated clinical research platform for research studies.Read full original descriptionShow less
The German Dementia Registry (DEMREG) is a large-scale national prospective biomarker-based study for cognitive impairment and dementia, providing an integrated clinical research platform for research studies.
Inclusion: Ability of the participant and/or his/her legally authorized representative (e.g., spouse or legal guardian), as appropriate and applicable, to understand the purpose and risks of the register and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local privacy regulations; Participating patients must have a diagnosis of SCD, MCI or early dementia of different etiology (i.e. Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease, Lewy-Body Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Normal Pressure Hydrocephalus, Major Depression; Vascular Dementia; TDP-43 associated limbic encephalopathy (LATE), Mixed Dementia AD + VaD, Prion-Associated Dementia) together with biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging; At least 18 years of age; At least 18 years of age; Patient was included in the registry; Family member is strongly involved to the patient's life according to the patient's statement; Ability of the participant, as appropriate and applicable, to understand the purpose and risks of the register.
Exclusion: Unwilling to provide informed consent; No available biomarkers such as cerebrospinal fluids (CSF) amyloid beta 1-42, amyloid beta 1-40, amyloid beta 1-42/amyloid beta 1-40 ratio, total tau and phosphorylated tau, amyloid or tau imaging; Unable or unwilling to provide informed consent.